A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus.
Muirhead R. et al, (2020), Clin Oncol (R Coll Radiol), 32, 874 - 883
Bluemke E. et al, (2020), Clin Transl Radiat Oncol, 22, 44 - 49
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.
Brown NF. et al, (2020), BMC Cancer, 20
Robinson M. et al, (2020), Radiother Oncol, 143, 19 - 23
A prospective study of diffusion-weighted magnetic resonance imaging for predicting outcome following chemoradiotherapy, in squamous cell carcinomas of the anus
Muirhead R. et al, (2019)
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.
McGowan DR. et al, (2019), Eur J Cancer, 113, 87 - 95
Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?
Sabbagh A. et al, (2019), Clin Oncol (R Coll Radiol), 31, 72 - 80
Muirhead R. et al, (2018)
Changes in Pelvic Active Bone Marrow seen on FDG-PET in Patients Receiving Concurrent Chemoradiation for Anal Cancer
Robinson M. et al, (2018)